Hyperpolarized [1-13C]-pyruvate MRS evaluates immune potential and predicts response to radiotherapy in cervical cancer is a research paper published in European Radiology Experimental (2024). On theSindex it has a DataRank of 0.293. It has been cited 5 times, with 4 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0.0239
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 4 citers.
National Science and Technology Council
Grant: MOST 109-2628-B-182A-007-
National Science and Technology Council
Grant: MOST 110-2628-B-182A-018-
National Science and Technology Council
Grant: MOST 111-2628-B-182A-012-
National Science and Technology Council
Grant: NSTC 112-2314-B-182A-127 -MY3
Chang Gung Medical Foundation
Grant: CLRPG3K0024
Chang Gung Medical Foundation
Grant: CMRPG3M0731
NIBIB NIH HHS
Grant: P41 EB013598
National Institutes of Health
Grant: 5P41EB013598-07
Hyperpolarized MRI Technology Resource Center
FWCI
0.82
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals